Clinical trial
Metabolic Reprogramming of Monocytes in Inflammatory Flares of Inflammatory Bowel Diseases
NCT06944873 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metabolic Reprogramming of Monocytes in Inflammatory Flares of Inflammatory Bowel Diseases
- Lead sponsor
- University Hospital, Grenoble
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- July 1, 2026
- Completion date
- July 31, 2028
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inflammatory bowel disease (ibd)